123 related articles for article (PubMed ID: 24254706)
1. RanBP9 overexpression down-regulates phospho-cofilin, causes early synaptic deficits and impaired learning, and accelerates accumulation of amyloid plaques in the mouse brain.
Palavicini JP; Wang H; Minond D; Bianchi E; Xu S; Lakshmana MK
J Alzheimers Dis; 2014; 39(4):727-40. PubMed ID: 24254706
[TBL] [Abstract][Full Text] [Related]
2. RanBP9 overexpression accelerates loss of pre and postsynaptic proteins in the APΔE9 transgenic mouse brain.
Wang H; Wang R; Xu S; Lakshmana MK
PLoS One; 2014; 9(1):e85484. PubMed ID: 24454876
[TBL] [Abstract][Full Text] [Related]
3. RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
Wang R; Palavicini JP; Wang H; Maiti P; Bianchi E; Xu S; Lloyd BN; Dawson-Scully K; Kang DE; Lakshmana MK
Neurobiol Dis; 2014 Sep; 69():169-79. PubMed ID: 24892886
[TBL] [Abstract][Full Text] [Related]
4. RanBP9 aggravates synaptic damage in the mouse brain and is inversely correlated to spinophilin levels in Alzheimer's brain synaptosomes.
Palavicini JP; Wang H; Bianchi E; Xu S; Rao JS; Kang DE; Lakshmana MK
Cell Death Dis; 2013 Jun; 4(6):e667. PubMed ID: 23764848
[TBL] [Abstract][Full Text] [Related]
5. RanBP9 overexpression reduces dendritic arbor and spine density.
Wang H; Lewsadder M; Dorn E; Xu S; Lakshmana MK
Neuroscience; 2014 Apr; 265():253-62. PubMed ID: 24486966
[TBL] [Abstract][Full Text] [Related]
6. RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction.
Woo JA; Boggess T; Uhlar C; Wang X; Khan H; Cappos G; Joly-Amado A; De Narvaez E; Majid S; Minamide LS; Bamburg JR; Morgan D; Weeber E; Kang DE
Cell Death Dis; 2015 Mar; 6(3):1676. PubMed ID: 25741591
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration.
Woo JA; Jung AR; Lakshmana MK; Bedrossian A; Lim Y; Bu JH; Park SA; Koo EH; Mook-Jung I; Kang DE
Cell Death Differ; 2012 Sep; 19(9):1413-23. PubMed ID: 22361682
[TBL] [Abstract][Full Text] [Related]
8. COPS5 protein overexpression increases amyloid plaque burden, decreases spinophilin-immunoreactive puncta, and exacerbates learning and memory deficits in the mouse brain.
Wang R; Wang H; Carrera I; Xu S; Lakshmana MK
J Biol Chem; 2015 Apr; 290(14):9299-309. PubMed ID: 25713139
[TBL] [Abstract][Full Text] [Related]
9. Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain.
Lakshmana MK; Hayes CD; Bennett SP; Bianchi E; Reddy KM; Koo EH; Kang DE
FASEB J; 2012 May; 26(5):2072-83. PubMed ID: 22294787
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway.
Roh SE; Woo JA; Lakshmana MK; Uhlar C; Ankala V; Boggess T; Liu T; Hong YH; Mook-Jung I; Kim SJ; Kang DE
FASEB J; 2013 Dec; 27(12):4776-89. PubMed ID: 23982146
[TBL] [Abstract][Full Text] [Related]
11. COPS5 (Jab1) protein increases β site processing of amyloid precursor protein and amyloid β peptide generation by stabilizing RanBP9 protein levels.
Wang H; Dey D; Carrera I; Minond D; Bianchi E; Xu S; Lakshmana MK
J Biol Chem; 2013 Sep; 288(37):26668-77. PubMed ID: 23926111
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE
Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855
[TBL] [Abstract][Full Text] [Related]
13. A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid-beta peptide generation.
Lakshmana MK; Chung JY; Wickramarachchi S; Tak E; Bianchi E; Koo EH; Kang DE
FASEB J; 2010 Jan; 24(1):119-27. PubMed ID: 19729516
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
15. Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice.
Tampellini D; Capetillo-Zarate E; Dumont M; Huang Z; Yu F; Lin MT; Gouras GK
J Neurosci; 2010 Oct; 30(43):14299-304. PubMed ID: 20980585
[TBL] [Abstract][Full Text] [Related]
16. Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid beta peptide generation.
Lakshmana MK; Yoon IS; Chen E; Bianchi E; Koo EH; Kang DE
J Biol Chem; 2009 May; 284(18):11863-72. PubMed ID: 19251705
[TBL] [Abstract][Full Text] [Related]
17. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
[TBL] [Abstract][Full Text] [Related]
18. Pivotal role of RanBP9 in integrin-dependent focal adhesion signaling and assembly.
Woo JA; Roh SE; Lakshmana MK; Kang DE
FASEB J; 2012 Apr; 26(4):1672-81. PubMed ID: 22223749
[TBL] [Abstract][Full Text] [Related]
19. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
20. Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.
Deng Y; Wei J; Cheng J; Zhong P; Xiong Z; Liu A; Lin L; Chen S; Yan Z
J Alzheimers Dis; 2016 Jun; 53(4):1419-32. PubMed ID: 27372643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
